Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.75
Bid: 40.00
Ask: 41.50
Change: 0.25 (0.62%)
Spread: 1.50 (3.75%)
Open: 40.20
High: 40.75
Low: 40.20
Prev. Close: 40.50
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

6 Jan 2020 15:38

RNS Number : 8950Y
Venture Life Group PLC
06 January 2020
 

6 January 2020

 

Venture Life Group plc

("Venture Life" or the "Company")

Grant of Options

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it has granted further share options ("Options") over ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares").

On 6 January 2020 (the "Date of Grant"), Venture Life granted Options over a total of 4,000,000 Ordinary Shares to its four Executive Directors at a strike price of 33.7 pence per share, being the average of the closing market price on the five business days starting 19 December 2019. Vesting of the Options is subject to continued employment. The Options will vest in equal tranches on the following dates: 31 March 2020, 31 March 2021 and 31 March 2022.

Director

Position

Number of Options in this grant

Jerry Randall

Chief Executive Officer

 1,000,000

Gianluca Braguti

Chief Manufacturing Officer

 1,000,000

Sharon Collins

Chief Commercial Officer

 1,000,000

Andrew Waters

Chief Financial Officer

 1,000,000

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.)

Names

1. Jerry Randall

2. Gianluca Braguti

3. Sharon Collins

4. Andrew Waters

2.

Reason for the notification

a.)

Position/status

1. Chief Executive Officer

2. Chief Manufacturing Officer

3. Chief Commercial Officer

4. Chief Financial Officer

b.)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.)

Name

Venture Life Group PLC

b.)

LEI

213800S8CZUPLAB2KC70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.)

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.3 pence each in Venture Life Group plc

b.)

Identification code

GB00BFPM8908

c.)

Nature of the transaction

Grant of Options over Ordinary Shares

d.)

Price and volumes

 

Price

Volume

1. 33.7 pence

2. 33.7 pence

3. 33.7 pence

4. 33.7 pence

1. 1,000,000

2. 1,000,000

3. 1,000,000

4. 1,000,000

 

 

e.)

Aggregated information

- Aggregated volume

- Price

 

n/a

f.)

Date of the transaction

6 January 2020

g.)

Place of the transaction

Outside a trading venue

 

For further information please contact: 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

Andrew Waters, Chief Financial Officer

 

Cenkos (Nominated Adviser and Joint Broker)

+44 (0) 207 397 8900

Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance) / Russell Kerr / Michael Johnson (Sales)

Alma PR

venturelife@almapr.com or +44 (0) 203 405 0208

Helena Bogle/Hilary Buchanan/Jessica Joynson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVELRIRIII
Date   Source Headline
7th Oct 201910:57 amRNSHolding(s) in Company
20th Sep 20197:00 amRNSHalf-year Report - Amendment
19th Sep 20197:00 amRNSInterim Results
17th Jul 20197:00 amRNSCommercial update
11th Jul 20193:33 pmRNSDirector/PDMR Shareholding
8th Jul 20195:02 pmRNSHolding(s) in Company
25th Jun 20198:44 amRNSDirector/PDMR Shareholding
3rd Jun 201911:36 amRNSResult of AGM
17th May 20194:35 pmRNSPrice Monitoring Extension
1st May 20197:00 amRNSAppointment of Chief Financial Officer
18th Apr 20197:00 amRNSFinal Results
26th Mar 20195:17 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNSNotice of Results Update
29th Jan 20197:00 amRNSTrading and Commercial Update
5th Dec 20183:26 pmRNSHolding(s) in Company
5th Dec 20188:12 amRNSHolding(s) in Company
23rd Nov 20187:00 amRNSChange of adviser and directorate update
15th Nov 20187:00 amRNSCommercial update
20th Sep 20187:01 amRNSDirectorate Change
20th Sep 20187:00 amRNSHalf-year Report
16th Aug 20187:00 amRNSTrading update & notice of interim results
13th Aug 201812:17 pmRNSHolding(s) in Company
8th Aug 20182:15 pmRNSHolding(s) in Company
8th Aug 20187:00 amRNSCompletion of Placing and Acquisition
7th Aug 20184:54 pmRNSHolding(s) in Company
7th Aug 201811:24 amRNSHolding(s) in Company
7th Aug 201811:24 amRNSHolding(s) in Company
7th Aug 201810:10 amRNSHolding(s) in Company
6th Aug 201811:51 amRNSResult of General Meeting
23rd Jul 20184:00 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSPlacing, proposed acquisition and notice of GM
20th Jul 20187:00 amRNSAppointment of Joint Broker
19th Jul 20183:38 pmRNSHolding(s) in Company
18th Jun 20187:00 amRNSIncreased distribution of UltraDEX in Boots, UK
4th Jun 20187:00 amRNSLloyds Pharmacy to list UltraDEX in UK
23rd May 201812:29 pmRNSResult of AGM
21st May 20187:00 amRNS'1000 Companies to Inspire Britain' 2018 report
9th May 20187:00 amRNSAlliance Pharma contract expansion and extension
8th May 20182:54 pmRNSHolding(s) in Company
30th Apr 20187:00 amRNSUltraDEX update
17th Apr 20187:00 amRNSDirector/PDMR Shareholding
5th Apr 20187:00 amRNSDirector/PDMR Shareholding
27th Mar 20187:00 amRNSDirector/PDMR Shareholding
26th Mar 20187:00 amRNS2018 LTIP and Grant of Options to PDMRs
22nd Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNotice of analyst & investor results briefings
16th Feb 20187:00 amRNSInvestor presentation
13th Feb 20187:00 amRNSCommerical update
31st Jan 20187:00 amRNSTrading update
8th Jan 20187:00 amRNSEuropean Business Awards 'Ones to Watch List'

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.